Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.02 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |